NAT10 and osteosarcoma: Together, these findings demonstrate a mechanism of ac4C driven RNA m6A modification and reveals a previously unrecognized signaling axis of NAT10-YTHDC1-LDHA/PFKM in osteosarcoma, shedding new light on the epigenetic regulation in human cancer.